Therapy of pemphigus.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010392:Pemphigus / Q000276:immunology / Q000401:mortality / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D003520:Cyclophosphamide; D003622:Dapsone; D001379:Azathioprine; D008727:Methotrexate